Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

ClinicalTrials.gov ID: NCT04498117

Public ClinicalTrials.gov record NCT04498117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed advanced ovarian cancer who have undergone optimal debulking.

Study identification

NCT ID
NCT04498117
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
CanariaBio Inc.
Industry
Enrollment
615 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 25, 2020 (Actual)
Primary completion
Dec 26, 2026 (Estimated)
Completion
Aug 26, 2028 (Estimated)
Last update posted
Apr 1, 2026

2020 – 2028

United States locations

U.S. sites
81
U.S. states
27
U.S. cities
73
Facility City State ZIP Site status
Honor Health Phoenix Arizona 85016 —
The University of Arizona Cancer Center Tucson Arizona 85724 —
John Muir Health Clinical Research Center Concord California 94520 —
Kaiser Permanente Southern California Irvine California 92120 —
Moores UC San Diego Cancer Center La Jolla California 92093 —
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027 —
Epic Care Pleasant Hill California 94523 —
Kaiser Permanente Riverside Medical Center Riverside California 95505 —
University of California, Davis Comprehensive Cancer Center Sacramento California 95817 —
Contra Costa Oncology Walnut Creek California 94598 —
John Muir Health Gynecologic Cancer Services Walnut Creek California 94598 —
University of Colorado Health Aurora Colorado 80045 —
University of Connecticut Health Center Farmington Connecticut 06030 —
Smilow Cancer Hospital New Haven Connecticut 06510 —
Yale University School of Medicine New Haven Connecticut 06510 —
AdventHealth Orlando Orlando Florida 32804 —
Women's Cancer Florida/Women's Cancer Associates St. Petersburg Florida 33701 —
Lewis Cancer & Research Pavilion at St. Joseph's Candler Savannah Georgia 31405 —
The Queens Medical Center Honolulu Hawaii 96813 —
Kapiolani Medical Center for Women and Children/University of Hawaii Honolulu Hawaii 96826 —
Parkview Research Center Fort Wayne Indiana 46845 —
Women's Cancer Care/Mary Bird Perkins Cancer Center Covington Louisiana 70433 —
Tufts Medical Center Boston Massachusetts 02111 —
Lahey Hospital and Medical Center Burlington Massachusetts 01805 —
MetroWest Medical Center Farmington Massachusetts 01702 —
Lowell General Hospital Lowell Massachusetts 01854 —
Tufts Medical Center Cancer Center in Stoneham Stoneham Massachusetts 02180 —
UMass Memorial Medical Center Worcester Massachusetts 01605 —
St. Joseph Mercy Hospital Ann Arbor Michigan 48106 —
Sparrow Hospital Lansing Michigan 48219 —
Minnesota Oncology Hematology - Mercy Hospital Coon Rapids Minnesota 55433 —
Minnesota Oncology Hematology Edina Minnesota 55435 —
University of Minnesota Health - Maple Grove Clinic Maple Grove Minnesota 55369 —
Minnesota Oncology Hematology Minneapolis Minnesota 55404 —
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 —
Park Nicollet Frauenshuh Cancer Center Saint Louis Park Minnesota 55426 —
Minnesota Oncology Hematology Saint Paul Minnesota 55102 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Portsmouth Regional Hospital Portsmouth New Hampshire 03801 —
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 —
The Valley Hospital (Valley Health) Paramus New Jersey 07450 —
Womens Cancer Care Associates Albany New York 12208 —
Mount Sinai - PRIME Lake Success New York 10019 —
Mount Sinai The Blavatnik Family Chelsea Medical Center New York New York 10011 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Stony Brook University Hospital Stony Brook New York 11794 —
Montefiore Medical Center PRIME The Bronx New York 10461 —
Duke University Durham North Carolina 27710 —
Duke Women's Cancer Care Raleigh Raleigh North Carolina 27607 —
SCC at UH Geauga Medical Center Chardon Ohio 44024 —
University Hospitals of Cleveland Cleveland Ohio 44106 —
Cleveland Clinic Fairview Hospital Cleveland Ohio 44111 —
Cleveland Clinic Cleveland Ohio 44195 —
Ohio State University Wexner Medical Center Columbus Ohio 43026 —
Grandview Medical Center/Kettering Medical Center Kettering Ohio 45429 —
Cleveland Clinic Hillcrest Hospital Mayfield Heights Ohio 44124 —
UH Minoff Health Center - Seidman Orange Ohio 44122 —
SCC at St. John's Medical Center Westlake Ohio 44145 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Oklahoma Cancer Specialist and Research Institution, LLC Tulsa Oklahoma 74146 —
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401 —
Northwest Cancer Specialists, P.C.-Portland-Rose Quarter Portland Oregon 97227 —
Magee Women's Hospital of UPMC Pittsburgh Pennsylvania 15213 —
UPMC Hillman Cancer Center at UPMC Passavant Pittsburgh Pennsylvania 15237-9643 —
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905 —
Sanford Research/USD-Sioux Falls Sioux Falls South Dakota 57104 —
Texas Oncology, P.A. - Austin Austin Texas 78731 —
Texas Oncology, P.A. Dallas Texas 75231 —
Texas Oncology, P.A. - Fort Worth Fort Worth Texas 76104 —
Memorial Herman Hospital Houston Texas 77030 —
Texas Oncology San Antonio Medical Center San Antonio Texas 78240 —
University of Virginia Health Systems Charlottesville Virginia 22903 —
Virginia Cancer Specialists Fairfax Virginia 21055 —
Virginia Oncology Associates - Hampton Norfolk Virginia 23502 —
VCU Massey Cancer Center Richmond Virginia 23298 —
Carilion Clinic Gynecological Oncology Roanoke Virginia 24106 —
MultiCare Regional Cancer Center - Auburn Auburn Washington 98001 —
MultiCare Regional Cancer Center-Gig Harbor Medical Park Gig Harbor Washington 98335 —
MultiCare Institute for Research and Innovation Puyallup Washington 98372 —
MultiCare Regional Cancer Center - Tacoma Tacoma Washington 98405 —
University of Wisconsin Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04498117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04498117 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →